However, fresh evidence from the HHS’ watchdog shows the problem is not a pushover FDA. If anything, the problem is a ...

Pharmaceutical Technology is the independent source for information, insight, and analysis on bio/pharmaceutical formulation, development, and manufacturing.

President Donald Trump’s nominee for FDA Commissioner, Martin A. Makary, MD, sought to assure senators that if confirmed, he would support efforts to expedite reviews of new drugs indicted for rare ...

Marty Makary, likely FDA commissioner under President Trump, appeared before Congress this week as the agency he’s set to lead continues to be rocked by sweeping changes and about-faces.

Shortly after bringing in a former FDA official to serve as its chief medical officer, Pfizer’s latest leadership appointment ...

The Senate hearing for FDA Commissioner nominee Marty Makary comes after President Trump's NIH pick, Jay Bhattacharya, was ...

As an FDA executive, Cavazzoni handed Pfizer, her former employer, a record-setting number of approved drugs in one year. And ...

according to the FDA's head of neuroscience Billy Dunn, director of the Centre for Drug Evaluation and Research (CDER) Patrizia Cavazzoni, and Peter Stein, the Director of CDER's Office of New ...

"It is the FDA's role to ensure that drugs are safe and effective," says Patrizia Cavazzoni, director of the administration's Center for Drug Evaluation and Research (CDER). "Based on our review of ...

The Vaccines and Related Biological Products Advisory Committee was supposed to meet on March 13 to recommend to the agency which flu strains should be included in influenza shots for the Northern ...

Collins "inverts the meaning" of systematic review's assessment of mask evidence, critic says. Top FDA official becomes ...

Revolving door is a VERY polite term for Patrizia Cavazzoni's moves. Then again, she has a 25-year history of picking Big Pharma over vulnerable patients. She'll fit right in with Scott Gottlieb.